about
Hot melt extrusion based solid solution approach: Exploring polymer comparison, physicochemical characterization and in-vivo evaluation.Design and Evaluation of Topical Diclofenac Sodium Gel Using Hot Melt Extrusion Technology as a Continuous Manufacturing Process with Kolliphor® P407.Meltlets(®) of soy isoflavones: process optimization and the effect of extrusion spheronization process parameters on antioxidant activity.Formulation and evaluation of trimetazidine dihydrochloride extended release tablets by melt congealing method.Development and Validation of Stability-Indicating RP-HPLC Method for Simultaneous Determination of Metformin HCl and Glimepiride in Fixed-Dose Combination.Solid crystal suspension of Efavirenz using hot melt extrusion: Exploring the role of crystalline polyols in improving solubility and dissolution rate.Development of hot melt co-formulated antimalarial solid dispersion system in fixed dose form (ARLUMELT): Evaluating amorphous state and in vivo performance.Solubility and dissolution enhancement of efavirenz hot melt extruded amorphous solid dispersions using combination of polymeric blends: A QbD approach.Artemether-Soluplus Hot-Melt Extrudate Solid Dispersion Systems for Solubility and Dissolution Rate Enhancement with Amorphous State Characteristics.Fabrication of cyclodextrin-templated mesoporous silica for improved dissolution of carbamazepine.Porous starch: a novel carrier for solubility enhancement of carbamazepine.Melt-in-mouth pellets of fexofenadine hydrochloride using crospovidone as an extrusion-spheronisation aidHot melt extruded amorphous solid dispersion of posaconazole with improved bioavailability: investigating drug-polymer miscibility with advanced characterisation.Comparison of dissolution profiles for sustained release resinates of BCS class I drugs using USP apparatus 2 and 4: a technical note.Stability Indicating HPTLC Determination of Meloxicam.Use of Placket-Burman statistical design to study effect of formulation variables on the release of drug from hot melt sustained release extrudatesStability indicating HPTLC determination of Trimetazidine as bulk drug and in pharmaceutical formulations.Trimetazidine: stability indicating RPLC assay method.Sustained ophthalmic delivery of ofloxacin from a pH triggered in situ gelling system.Stability indicating HPTLC determination of timolol maleate as bulk drug and in pharmaceutical preparationsStability indicating reversed-phase liquid chromatographic determination of ciprofloxacin as bulk drug and in pharmaceutical formulationsLiquid antisolvent precipitation process for solubility modulation of bicalutamide
P50
Q31035999-3C6A4DAB-C22E-4D59-854F-1FBE0AFCF631Q36256251-F0260A65-204D-4DFE-8B21-F9C6C83699B6Q37318933-17B45972-B5CA-42BD-AF2D-7ADBA3A94632Q38549226-24A57A91-8E75-42F2-AB02-106EA5084BACQ38981360-BDDF9E35-EAE7-472F-8639-519A0DF77F9BQ39154816-495EF356-A842-4D9A-AA2B-63F95EE73073Q39182052-A8B1064F-FEA4-4929-83BA-79962DF35712Q39860239-73870E20-12D7-4A98-987B-DD71CB91E43AQ40335976-D1A000D9-FA1E-4619-88C0-902EE38E5E9CQ41195863-8708E424-2B3E-4515-AB5C-A0449F2901D1Q41833900-EF064595-35DD-435E-8325-F13C4A24BEADQ41988830-6239A26B-FB37-4CBC-BE1D-FB01CD910708Q42114941-2CC4E516-C36C-4ED9-8BB8-E8E597E428F3Q42204577-DDEA6BD0-2406-4767-99A2-FC194FFBAA68Q42599229-4F318BDD-33D1-4554-B990-17D516BC379EQ42734616-CBF51B72-576F-463E-80B8-BA4DCF4B04E2Q43557207-0BF80AC3-5D8B-48A1-9885-08D4DEDE89D4Q43557611-AC7DE33D-EFA3-40A7-B860-235C6837384FQ43715309-BD28FE12-09A0-4BA7-B0D4-301019DA7D3BQ73234005-512C5DDA-56E5-4D45-8983-5024CB94F241Q73683880-77E1AADB-B3F5-4BA2-912E-3422D0C0A0E6Q83143505-81212AAC-E514-49EA-B1E7-666393FF6A53
P50
description
researcher
@en
wetenschapper
@nl
name
P D Amin
@en
P D Amin
@nl
type
label
P D Amin
@en
P D Amin
@nl
prefLabel
P D Amin
@en
P D Amin
@nl
P106
P31
P496
0000-0002-4366-4144